These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10808079)

  • 1. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
    Ruiz A; Durand J
    Brain Res Bull; 2000 May; 52(2):99-107. PubMed ID: 10808079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of kainate-induced responses by pentobarbitone and GYKI-53784 in rat abducens motoneurons in vivo.
    Ruiz A; Durand J
    Brain Res; 1999 Feb; 818(2):421-30. PubMed ID: 10082828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
    Parsons CG; Gruner R; Rozental J
    Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of AMPA receptors in trigeminal post-synaptic potentials recorded in rat abducens motoneurons in vivo.
    Ouardouz M; Durand J
    Eur J Neurosci; 1994 Nov; 6(11):1662-8. PubMed ID: 7874305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones.
    Ouardouz M; Durand J
    Neurosci Lett; 1991 Apr; 125(1):5-8. PubMed ID: 1830380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of intravenous NBQX and GYKI 53655 as AMPA antagonists in the rat spinal cord.
    Chizh BA; Cumberbatch MJ; Headley PM
    Br J Pharmacol; 1994 Jul; 112(3):843-6. PubMed ID: 7522860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local mechanisms of phase-dependent postsynaptic modifications of NMDA-induced oscillations in the abducens motoneurons: a simulation study.
    Kopysova IL; Korogod SM; Durand J; Tyc-Dumont S
    J Neurophysiol; 1996 Aug; 76(2):1015-24. PubMed ID: 8871216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPA receptor antagonists, GYKI 52466 and NBQX, do not block the induction of long-term potentiation at therapeutically relevant concentrations.
    Kapus G; Székely JI; Durand J; Ruiz A; Tarnawa I
    Brain Res Bull; 2000 Aug; 52(6):511-7. PubMed ID: 10974490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists.
    Yamada KA; Turetsky DM
    Br J Pharmacol; 1996 Apr; 117(8):1663-72. PubMed ID: 8732274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of NMDA and non-NMDA excitatory amino acid receptors in the mediation of spinal reflex potentials in rats: an in vivo study.
    Farkas S; Ono H
    Br J Pharmacol; 1995 Mar; 114(6):1193-205. PubMed ID: 7620709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles for NMDA and non-NMDA receptor subtypes in baroreceptor afferent integration in the nucleus of the solitary tract of the rat.
    Zhang J; Mifflin SW
    J Physiol; 1998 Sep; 511 ( Pt 3)(Pt 3):733-45. PubMed ID: 9714856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic excitation triggers oscillations during NMDA receptor activation in rat abducens motoneurons.
    Durand J
    Eur J Neurosci; 1993 Oct; 5(10):1389-97. PubMed ID: 7903893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excitatory amino acids and synaptic transmission in embryonic rat brainstem motoneurons in organotypic culture.
    Launey T; Ivanov A; Kapus G; Ferrand N; Tarnawa I; Gueritaud JP
    Eur J Neurosci; 1999 Apr; 11(4):1324-34. PubMed ID: 10103128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late embryonic expression of AMPA receptor function in the CA1 region of the intact hippocampus in vitro.
    Diabira D; Hennou S; Chevassus-Au-Louis N; Ben-Ari Y; Gozlan H
    Eur J Neurosci; 1999 Nov; 11(11):4015-23. PubMed ID: 10583490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GYKI 53665, a 2,3-benzodiazepine, non-competitively protects cultured neurones against AMPA toxicity.
    Kovács AD; Szabó G
    Eur J Pharmacol; 1997 Jul; 331(1):93-6. PubMed ID: 9274935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655.
    Palmer AJ; Lodge D
    Eur J Pharmacol; 1993 Jan; 244(2):193-4. PubMed ID: 7679352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPA receptors have an equal role in spinal nociceptive and non-nociceptive transmission.
    Cumberbatch MJ; Chizh BA; Headley PM
    Neuroreport; 1994 Apr; 5(8):877-80. PubMed ID: 7520299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution.
    Randle JC; Guet T; Cordi A; Lepagnol JM
    Eur J Pharmacol; 1992 May; 215(2-3):237-44. PubMed ID: 1382998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of YM90K, a selective and potent antagonist of AMPA receptors, in rat cortical mRNA-injected Xenopus oocytes.
    Okada M; Kohara A; Yamaguchi T
    Eur J Pharmacol; 1996 Aug; 309(3):299-306. PubMed ID: 8874154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.